Global patent filings grow at their fastest for 18 years

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Global patent filings grow at their fastest for 18 years

Applications from the Chinese for IP rights around the world have helped to drive levels of global IP growth in 2012, with global patent filings growing at their fastest rate for 18 years

The 2013 edition of WIPO’s World Intellectual Property Indicators, published today, reveals that, for the first time, China tops the ranking for both the source (filings by China) and the destination (filed in China) for patents, utility models, trade marks and industrial designs.

Of the top five IP offices worldwide (USPTO, JPO EPO, KIPO and SIPO), the Chinese State Intellectual Property Office was the only one to record double-digit growth for each of the four types of IP.

The rapid growth of IP applications into and from China contributed to 2012 as being the year in which global patent filings increased at its strongest rate in nearly two decades. Last year patent applications from individual inventors and companies topped 2.35 million, 9.2% more than in 2011.

But the growth in patent applications was distributed unevenly. SIPO saw the fastest growth in filings, up almost one-quarter on 2011. New Zealand followed with 14%, and Mexico with 9%. While other Bric countries saw applications rise by at least 2.7%, the picture in Europe was more mixed.

While the EPO, the UK and Germany each attracted at least 3.2% more applications for patents in 2012 compared to the year before, France and Italy each saw a dip in the number of applications received by their national offices.

IP offices in Europe also reported a dip in the number of trade mark classes for which applicants sought protection in 2012. While class counts filed world wide grew by 6% (although this was at a slower pace than in the previous two years), Italy saw an 8.3% decrease, while Germany and Spain reported falls of 6.4% and 5.6%, respectively.

In 2012, residents of China filed, worldwide, applications with more than 1.5 million class counts, almost triple the level from the US and almost four times as many as originated from France and Germany.

Following a slowdown in both 2008 and 2009, the numbers of industrial designs contained in applications has continued to rise. Last year applications grew by 17%.

“Following the 2009 financial crisis, global IP filings and global economic output have followed diverging paths,” said WIPO director-general Francis Gurry.“While economic recovery since the 2009 crisis has been uneven and has failed to bring down unacceptably high levels of unemployment, IP filings have increased at a faster rate than before the crisis.”

more from across site and SHARED ros bottom lb

More from across our site

The team, comprising two partners and one senior consultant, plans to offer “highly differentiated” services to clients
HGF’s new ownership model frees it from the hiring constraints of traditional partnerships, its CEO told Managing IP
New timeline for 2026 aims to provide clearer guidance to firms and practitioners on the full jurisdictional market view
Attorneys contemplate whether clients using AI for legal guidance is beneficial to attorney-client relationships or more of a nuisance
Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms
An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Gift this article